© Copyright Nostre Net
Market Highlights
According to MRFR analysis, Cell
Counting Market trends is expected to register a CAGR of 5.8% during
the forecast period of 2019 to 2025 and was valued at USD 8.47 Billion
in 2018.
Cell counting is important for research and serves as one of
the major steps in the majority of experiments. It is effectively utilized for
maintaining cell cultures. Moreover, another important application of cell
counting can be seen in the diagnosis of chronic diseases like cancer. For
instance, an increase in the number of white blood cells (WBC) may indicate the
possibility of cancerous growth in the body. Thus, cell counting is important
for microbiology, hematology and other medical specialties.
The growth of the global cell counting market is determined
by numerous factors such as increasing R&D expenditure, rising prevalence
of cancer, and product launches. However, the high cost of devices and product
recalls are projected to restrain the growth of the market during the forecast
period.
The Global Cell Counting Market is currently dominated by
several market players. The key players are involved in product launches,
expansion, and strategic collaborations to strengthen their market positions.
Recently in April 2019, the Nexcelom Bioscience LLC launched Cellaca MX
automated cell counter.
Regional Analysis
The Cell
Counting Market Report has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share
owing to the increase in the incidence of cancer and the presence of well-established
pharmaceutical and biotechnology industry. The cell counting market in the
Americas has further been branched into North America and Latin America, with
the North American market divided into the US and Canada.
The European cell counting market has been categorized as
Western Europe and Eastern Europe. The Western European market has further been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The cell counting market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the
presence of a large patient pool and expansion of healthcare facilities, the
market in Asia-Pacific is expected to be the fastest-growing. The cell counting
market in the Middle East & Africa has been divided into the Middle East
and Africa.
Segmentation
The Global Cell Counting Market has been segmented based on
product, application, and end-user.
The market, based on type, has been divided into consumables
and instruments. The consumable segment is likely to hold maximum
market share in the global cell counting market. This due to the repeated
purchase of the consumable compared with instrument products.
The global cell counting market based
on application has been segregated into research application,
clinical & diagnostic application, and others. The research application
segment is anticipated to hold the largest share in the market due to the
rising funding for stem cell research.
The end-user segments of the market are pharmaceutical
and biotechnology companies, hospitals, research institutes, and others. The
pharmaceutical and biotechnology companies’ segment is expected to hold the
largest share of the market, as these are used cell counting products in
research and development of new drugs and therapies.
Key Players
Some of the Key Players in the Global Cell Counting
Market are Thermo Fisher Scientific (US), Merck KGaA (Germany),
Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Logos Biosystems,
Inc. (South Korea), Olympus Corporation (Japan), Agilent Technologies, Inc.
(US), PerkinElmer, Inc. (US), Sysmex Corporation (Japan), Abbott Laboratories
(US), and others.
The pain
patch market share is expected to reach USD 21324 Million by 2030 at
4.80% CAGR during the forecast period 2022-2030. Pain-relief patches also known
as pain patches can be easily purchased from pharmacies. They are available in
different types, however, most of the pain patches are used for managing both
short-term and long-term pain. This clearly means that a pain patch can be
prescribed for both acute and chronic pain conditions. This flexibility and
effectiveness helps the companies in the global market for pain patch grow as
the demand for these products remains strong throughout the year, and its easy
availability has given more boost to the market.
A pain patch market when placed on the skin
helps the skin absorb a certain amount of medication which helps prevent or
reduce pain. The medication easily gets absorbed into the bloodstream, however
the type of medication and patch prescribed by physicians may vary depending on
the actual need of the patients and levels of the pain. Prescription based pain
patches may include diclofenac epolamine, an anti-inflammatory nonsteroidal
drug, a local anesthetic known as lidocaine, and opioid pain medication.
For minor injuries, physicians recommend a
pain patch with diclofenac epolamine. This formula helps in reducing and
controlling minor pain caused due to muscle strains and sprains. This element
falls under the same group as ibuprofen and aspirin. Patients are asked to be
careful and not use such patches anywhere on a broken skin. A study published
by expert analysts has found that such pain patches can provide pain relief for
soft-tissue injuries with few adverse effects.
Pain Patch Market Key Players
Pain Patch Market Segmentation
For the scope of research, analysts have
segmented the pain
patch market Outlook based on type, mode of administration, end users, and
therapeutic use.
Pain Patch Market Regional Overview
Industry experts have analyzed the global
pain patches market at different levels. The report brings information from
across the world and provides key insights into regional pain patch markets
from the Americas, which is the largest market in the world for pain patches.
The growth here is due to an increasing number of patients with chronic
diseases and spinal injury. The report also covers the European market where
demand for pain patches is on the rise. Other regional pain patch markets covered
in the report are Asia-Pacific and the Middle East and Africa. For each of
these regions, analysts have also presented country-level trends, predictions,
and market status details along with profiling of key players present in the
global pain patch market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Highlights
Automatic
Pill Dispenser Market Overview and analysis by Type, End User and Region -
Forecast till 2030. The increasing prevalence of cardiovascular
disorders and growing older population are the key factors driving the
automatic pill dispenser market. As per the report published by the Centers for
Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were
dealing with at least one type of cardiovascular disease.
The Global Automatic Pill Dispenser Market is expected to
grow significantly over the forecast period. It is anticipated that the market
held a valuation of USD 5.71 Billion in 2022-2030 and is projected to register
a CAGR of 8.5% over the forecast period.
Various other factors such as the advancements
in automatic pill dispenser, increasing geriatric population,
untapped emerging markets, rise in regulatory approvals, and
increasing investment on home care centers are also expected to propel the
growth of the market.
However, the high cost of the system can hamper
market growth over the forecast period.
Segmentation
The global automatic pill dispenser market is segmented
based on type, end user, and region.
The global market for automatic pill dispenser, by type, is
segmented into a centralized, automated dispensing system, and decentralized
the automated dispensing system. The centralized, automated dispensing system
is further classified into robotic automated dispensing systems, and carousels.
Furthermore, the decentralized automated dispensing system is classified into a
pharmacy-based automated dispensing system, ward-based automated dispensing
system, and automated unit dose dispensing system.
Based on end user, the market is segmented into hospital
pharmacy, retail pharmacy, and home healthcare.
The centralized, automated dispensing system segment is
expected to witness the fastest growth over the forecast period due to
increasing adoption in various hospitals as well as other healthcare
facilities.
Key Players
Some of the key players in the global automatic pill
dispenser market are Baxter International Inc, Becton, Dickinson and Company,
Cerner Corporation, Capsa Healthcare, McKesson Corporation, Omnicell Inc.,
ScriptPro LLC, Swisslog Holdings AG, Yuyama Co.Ltd. Talyst, Inc., and others
Regional Analysis
In the current scope of the study, the segments mentioned
above are covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The automatic
pill dispenser market research report in the Americas has further been
segmented into North America and South America, with the North American market
divided into the US and Canada.
The European automatic pill dispenser market has been
segmented into Western Europe and Eastern Europe. Western Europe has been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The automatic pill dispenser market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. The automatic pill dispenser market in the Middle East &
Africa has been segmented into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Highlights
Craniomaxillofacial
(CMF) Devices Market Overview by Product, Material, Application and Region -
Forecast till 2030. The Craniomaxillofacial (CMF)
Devices Market is expected to grow significantly over the forecast period. It
is anticipated that the market held a valuation of USD 4,239.37 million in 2020
and is projected to register a CAGR of 9.40% over the forecast 2020-2030. The
increasing participation of key players is one of the key factors driving
the craniomaxillofacial devices market. In 2019, Kelyniam Global
(KLYG) received premarket FDA approval for unique modifications to their PEEK
cranio-maxillofacial implant product line.
Key Players
Some of the key players in the global CMF
devices market are Aesculap Implant System LLP, Johnson & Johnson,
Kanghui Orthopedic, OsteoMed, KLS Martin, MATRIX SURGICAL USA, Integra
Lifesciences Corporation, Medtronic, Medartis AG, Stryker, Corporation, TMJ
Concepts, W.L. Gore and Associates, Zimmer Biomet Inc., and others.
Segmentation
The global craniomaxillofacial devices
market is segmented based on product, material, application, end user, and
region.
The global market for craniomaxillofacial
(CMF) devices, by product, is segmented into cranial flap fixation,
craniomaxillofacial fixation (CMF) distraction, temporomandibular joint
replacement
thoracic fixation, bone graft substitute,
CMF plate, and screw fixation, and dural repair. The dural repair segment is
further classified as dural sealants and dural substitutes.
Based on material, the market is segmented
into metals and alloys, bioabsorbable, ceramics, polymers, and others.
Based on application, the market is
segmented into neurosurgery, ENT, orthognathic & dental surgery, plastic
surgery, and others.
Based on end user, the market is segmented
into hospitals, ambulatory surgical centers, and others.
The ambulatory surgical centers segment is
expected to witness the fastest growth over the forecast period due to
rising acceptance of craniomaxillofacial (CMF) devices in ambulatory
settings.
Regional Analysis
In the current scope of the study, the
segments mentioned above are covered into the four global regions, namely, the
Americas, Europe, Asia-Pacific, and the Middle East and African region.
The CMF devices market in the Americas has
further been segmented into North America and South America, with the North
American market divided into the US and Canada.
The European CMF devices market has been
segmented into Western Europe and Eastern Europe. Western Europe has been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The CMF devices market in Asia-Pacific has been segmented into
Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The
Craniomaxillofacial (CMF) Devices market in the Middle East & Africa has
been segmented into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Medical
Oxygen Concentrators Market Overview by Product, Technology, Indication, End
User and Region - Forecast till 2030.The medical oxygen concentrators
market size is expected to reach USD 4.8 billion by 2030 at 5% CAGR during the
forecast period 2022-2030.Demand for oxygen therapies had been rising in the
last couple of decades as numerous studies have pointed out that patients who undergo
oxygen therapy live longer and lead more active lives. Medical oxygen
concentrators market has therefore been expanding as oxygen concentrators have
come to be increasingly used in not only hospitals and clinics but at homes by
patients who require outpatient treatments or patients who wish to travel and
continue to lead normal lives with considerable mobility in spite of the need
for continuous requirement of oxygen supply.
Oxygen
concentrators are less portable than the other options. An oxygen concentrator
is a device that takes oxygen from the room, concentrates it for therapeutic
use, and removes other naturally occurring gases. The benefits of concentrators
are that they are less expensive and don’t require filling like tanks. Portable
versions are available. However, most models are too large to be truly
portable.
Competitive Landscape:
Some of the
companies that are making considerable contribution to the medical oxygen
concentrators market include Philips Healthcare, Invacare Corporation, AirSep
Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart
Industries, Inc., Nidek Medical Products, Inc., Precision Medical, Inc., GCE
Group, Besco Medical Limited, O2 Concepts, LLC, Inogen, Teijin Limited, OSI -
Oxygen Solutions Inc.
Segmentation
The global medical oxygen concentrators
market has been segmented into product, technology, indication, end user, and
region.
By product, the market has been segmented
into portable oxygen concentrators and stationary oxygen concentrators.
On the basis of technology, the market has
been divided into the continuous flow and pulse dose.
Based on indication, the market has been
categorized into chronic obstructive pulmonary disease, asthma, sleep apnea,
and others.
By end user, the market has been classified
into homecare, travel, hospitals and clinics, and others. Home oxygen
concentrators facilitate convenience and make it easier and safer for the
patient to complete their day-to-day activities, which is supporting the
dominance of the homecare segment during the next six years.
Regional Analysis:
Geographically,
the North America held a substantial share in the medical
oxygen concentrators market research report in 2018 which can be attributed
to the presence of established home healthcare care services, active
participation of key market players, increasing incidence of respiratory
diseases, and favorable reimbursement scenario in the U.S. and Canada.
Expanding
geriatric population in Europe coupled with rising prevalence of asthma,
pulmonary hypertension, COPD, and fibrosis, would lead the region to be
the second largest value contributor to the medical oxygen concentrators
market.
Increasing
healthcare expenditure, improvement in healthcare infrastructure and expanding
awareness about need for oxygen concentrators will augment Asia-Pacific medical
oxygen concentrators market growth. The region is anticipated to register the
fastest market CAGR over 2018-2024 owing to increasing demand for portable
concentrators.
The medical
oxygen concentrators market in the Middle East & Africa would witness the
modest market growth rate from 2018 to 2024. The Middle East would spearhead
the market attributed to the rising prevalence of sleep apnea.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
The global ultrasound
devices market share is expected to exhibit a strong 8.1% CAGR over the
forecast period, rising to a valuation of USD 10.37 billion by 2023, according
to a new report from Market Research Future (MRFR). The report elaborates on
the major drivers and restraints for the global ultrasound devices market in
detail by analyzing their impact on the market’s trajectory over the forecast
period.
The growing
demand for ultrasound devices for diagnostic purposes is likely to be the major
driver for the global ultrasound devices market over the forecast period.
Ultrasound devices work by sending out high-frequency sound waves that provide
a picture of the targeted area based on the response of various bodily tissues
to the sound waves. Since different tissues react differently to the same sound
waves, the technique has become popular in the healthcare sector. The lack of
invasion in the use of ultrasound equipment manufacturers has also become a key
plus point for the market due to the growing obsession with minimally invasive
and noninvasive medical procedures. Therapeutic applications of ultrasound
include targeting a specific patch of tissue for stimulation or removal by
bombarding it with high-frequency sound waves. This application is also likely
to remain a key factor for the global ultrasound devices market’s growth over
the forecast period.
The growing
demand for more advanced ultrasound devices in the gynecology sector is likely
to be a major driver for the global ultrasound devices market over the forecast
period. The development of 3D and 4D ultrasound imaging has allowed for the
diagnosis of congenital defects clearly and earlier in the pregnancy, which has
made the procedures widely popular in the healthcare sector around the world.
4D imaging also allows live action viewing of the fetus, which allows
physicians to detect more abnormalities. This is likely to be a major driver
for the global ultrasound devices market over the forecast period.
Competitive Analysis:
Leading players
in the global ultrasound devices market include Siemens AG, GE, Hitachi Ltd.,
Shimadzu Corporation, Analogic Corporation, Mindray Medical International Ltd.,
Toshiba Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips NV.
Segmentation
Analysis:
By portability, cart/trolley-based devices
accounted for the largest market share in 2017 due to its utilization in acute
and emergency care settings. The segment is likely to register strong CAGR
during the forecast period expected to hold significant market share during the
forecast period. Handheld/compact ultrasound devices accounted for the second
largest share due to the rising adoption of these by healthcare professionals.
By display, color devices accounted for a
largest market share in 2017 compared to its counterpart, black/white
ultrasound devices. The former can touch a size of USD 7,509.12 million by
2026, while the latter is likely to show prominent growth by the end of the
forecast period.
By application, radiology/general imaging is
likely to register highest CAGR during the assessment and likely to dominate
the market by 2026. It accounted for the largest market share in 2017 due to
its vast medical applications. The rising geriatric populace and incidence of
various cancers can spur the segment growth. On the other hand, cardiology is
also showing significant growth by 2026.
By technology, diagnostic accounted for the
largest market share in 2017 due to the use of 2D ultrasound in women’s health.
It is likely to show CAGR over the assessment period and hold significant
market share by 2026 due to the continuous advances in imaging and
reimbursement schemes for these procedures. On the flip side, therapeutic
ultrasound is expected to hold second position by 2026.
By end-user, hospitals and diagnostic &
surgical centers dominated the ultrasound devices market in 2017 due to
emergence of various hospital chains and rising number of minimally invasive
diagnostic procedures by doctors. The segment can grow with strong CAGR and
expected to hold first position in the market. Ambulatory care centers can
exhibit the highest CAGR of 3.61% during the forecast period thanks to the
facilities providing same-day care diagnostic and surgical procedures.
Regional Analysis:
The Americas is
likely to be the major regional market for ultrasound devices over the forecast
period due to the widespread adoption of advanced ultrasound technology in the
region and the growing demand for advanced diagnostic modalities and devices.
Europe is also likely to remain a major regional market for ultrasound devices
over the forecast period due to the growing healthcare expenditure in the
region. Asia Pacific is expected to exhibit the fastest growth over the
forecast period due to the growing demand for advanced medical facilities and
devices and the increasing investment in hospitals and medical technology.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Market Insights
According to the report published by Market Research
Future, the global The Endodontic
Devices market size is projected to reach USD 1536.96 Million by 2030 at
4.90% CAGR during the forecast period 2022-2030.
The central soft pulp of a tooth comprised of blood vessels
and nerves, when infected cause sensation of heat and pain, and swelling,
hence, create discomfort. The prime intention of endodontic surgery, the root
canal, is to keep the tooth intact, but just remove the infected or injured
pulp. The increase in intake of food enriched with fat and starch is
contributing to the surge in number of people suffering from dental malaises.
The urge to maintain the dental setup owing to aesthetic purpose is increasing
the adoption of root canal among people. This is boosting the use of endodontic
devices. MRFR identifies these as factors expected to cast a positive impact on
the global endodontic market growth. However, on the downside, certain factors
like the high cost, the possibility of enamel loss, and risk of abnormal
bleeding and abscess can hinder the endodontic devices market expansion.
Regional Overview
The demographic progress of the endodontic devices market is
evident from the regional segmental study of the market. Based on region, the
endodontic devices market study has been performed across North America, Latin
America, Asia Pacific, Europe, and the Middle East Asia and Africa.
The North and Latin American endodontic devices market is
expected to be at the forefront over the assessment period. Due to unhealthy
changes in the food habit, a surge in the prevalence of dental disease is
observed. This is the leading factor that is anticipated to fuel the
endodontics devices market in the near future.
The large number of people suffering from dental ailments,
in Europe is boosting the need for proper dental care. This in turn, is
increasing the adoption of root canal treatment and dental products. MRFR
forecasts the European endodontics devices market to follow the lead, and grow
at a rapid pace.
The Asia Pacific endodontic devices market is expected to be
the fastest growing in the coming years. According to the United Nations ESCAP,
the geriatric population in this region, by 2050 is expected to be around 1.3
billion people. This is expected to shoot up the regional market growth curve.
The rapidly proliferating healthcare industry and development of advanced
treatments are other factors bolstering the market growth in this region. The
south-east Asia is anticipated to show a promising growth over the forecast
period owing to the increase in the number of dental malaise cases.
The Middle East Asia and Africa is projected to hold the
least share in global endodontic devices market. Political loopholes,
socio-economic backwardness, low per capita income are responsible for the
lagging market growth in the region. However, increase in the governments
funding, supporting research and developmental activities in the healthcare
industry and developed economies like Kuwait, Dubai, UAE, and others can
stimulate the market growth in the upcoming years.
Segmental Analysis
The endodontic
devices market’s Insights segmental study offers a comprehensive
understanding of the market that assists in the identification of new growth
opportunities to augment the market expansion. The global endodontic
devices market study has been segmented into end user and product.
On the basis of end user, the endodontic devices market
has been segmented into dental clinics, dental hospitals, laboratories, and
dental academic and research institutes.
On the basis of product, the endodontic devices market
has been segmented into consumables and instruments. The consumables segment
has been classified into endodontic burs, endodontic files and shaper,
irritating solution and lubricants, obturation filling materials, and others.
The instruments segment has been narrowed down to apex locators, endodontic
scalers, machine-assisted obturation systems, handpieces, and endodontic
lasers.
Key Players
Davis Schottlander & Davis Ltd, Hu-Friedy Mfg. Co., LLC,
DiaDent Group International, COLTENE Holding, Kerr Corporation, Ivoclar
Vivadent, Ultradent Products, Septodont, Brasseler USA, Surtex Instruments
Limited, DENTSPLY SIRONA, Danaher Corporation, MICRO-MEGA, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Gene
Expression Analysis Market Share will show a steady growth rate in the
forecast period. It will reach a valuation of USD 7362.06 million and register
a CAGR of 10.30 % during the forecast period by 2030. Personalized
medicine, with its ability to affect diagnostic and treatment decisions for
every patient, has brought an evolution in modern medicine. Diagnosis,
treatment, as well as lifestyle interventions, have now become progressively
personalized to every patient genetics, family history along with other
factors.
Technologies have made it easier for
healthcare professionals to track every patient’s health information and offer
personalized care. Personalized medicine has gained immense traction as a
result of the boost in the number of genetic disorders. Additionally, the
mounting awareness about this form of treatment will drive the market in the
near future. The rising technological advancement including molecular services
and NGS are uplifting the demand for gene expression services. This factor will
ensure the success of the gene expression analysis market during the evaluation
period.
The downside could be the high cost of
instruments, hindering the market growth in the review period. But the
development of genomic databases, surge in government funding towards genomics,
and increasing personalized medicine are projected to elevate the market
position in the subsequent years.
Leading Vendors
Agilent Technologies, Inc., Bio-Rad
Laboratories, Inc., F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Pacific
Biosciences of California, Inc., Illumina, Inc., Genotypic Technology Pvt Ltd,
Danaher, QIAGEN, Oxford Gene Technology, Thermo Fisher Scientific, BGI,
PerkinElmer Inc., Macrogen Inc., Eurofins Scientific, are some of the companies
currently leading the worldwide gene expression analysis market.
Market Segmentation
The global Gene
Expression Analysismarket Outlook for epigenetics drugs has been
segmented on the basis of product, services, application, and end-user.
The market, product-wise, include
consumables and instruments.
Depending on consumables, the market covers
reagents and DNA chips.
Instruments-based segments in the market
are polymerase chain reaction (PCR), next-generation sequencing (NGS),
microarray, Sanger sequencing, and others.
The services mentioned in the report are
gene expression profiling services, sequencing services, bioinformatics
solutions, and others.
Gene expression analysis finds applications
in drug discovery, diagnosis, research, and others.
The end-users highlighted in the report are
pharmaceutical & biotechnology companies, academic & research
institutes, contract research organizations, and others.
Regional Outlook
The primary markets for gene expression
analysis are Europe, Asia Pacific, Middle East & Africa and the Americas.
During the forecast period, the Americas
could very well reach the top position in the global gene expression analysis
market, estimates MRFR. The highly-established infrastructure, huge
expenditure, and increasing research and development activities in the region
play a big role in this growth. The market also gets a boost from the large
number of established players based in the region. Case in point is GE
Healthcare, which alone generated revenue of USD 19.1 Billion in 2017.
Standing at the second spot, Europe is now
an established region in the global gene expression analysis market. The
regional market gains from the numerous government initiatives taken in
research and development associated with gene expression analysis. Europe is also
inundated with esteemed companies such as F. Hoffmann-La Roche Ltd. To
illustrate, F. Hoffmann-La Roche, in February 2018, had received an approval
from the U.S. Food and Drug Administration (FDA) for its multiplex Factor V and
Factor II assessment which could be used on Cobas 4800 systems. This system is
known for achieving real-time PCR analysis for high volume labs.
Asia Pacific could expect the fastest
growth in the worldwide market. The rising number of global partnerships for
the expansion of the region’s healthcare sector, government focus on cancer as
well as life science research and internal manufacturing of the sequencing
systems favors the regional market. Other factors promoting market growth could
be the massive R&D investments and the booming bioresearch centers. On top
of this, the surge in the number of research activities in agriculture and the
growing approval of gene expression tests add to the market’s strength.
Middle East and Africa could project weak
growth in the coming years on account of substandard healthcare amenities and
low fund investments associated with research and development activities.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global market report on the orphan drugs revealed a possibility
of crossing a valuation of USD 355 Billion by the end of 2030 with a CAGR of 9.2%
during the forecast period of 2022-2030. Market Research Future (MRFR) in an
exclusive report revealed factors that may improve the market scenario by
substantial margin in the coming years. These factors are growing demand for
the orphan drugs for the treatments of rare diseases, increasing initiatives
taken by various governments, and others. Orphan drugs are exclusive as their
production rarely takes place under a normal circumstance.
This is also the reason that increases the production cost
of the drug owing to which the growth of the orphan
drugs market may take a hit in the coming years. But growth in FDA
approvals may alter the market scenario.
Segmentation:
MRFR dug deep into the market to gain insights regarding
various procedures and it included a proper segmentation of the market. The segmentation
includes drug type, sale, drug, and therapy class.
By therapy class, the global report on the orphan drugs
segmented the market into oncology, blood, central nervous systems, endocrine,
cardiovascular, and respiratory. The oncology segment would get backed by a
huge demand for such medicines as the number of cancer patient is rising.
By drug, the report covers Keytruda, Imbruvica, Revlimid,
Rituxan, Opdivo, Jakaf, Pomalyst, Spinraza, Darzalex, Soliris, and
Adcetris.
By sale, the report on the orphan drugs market is covering
segments like generics and prescribed. The prescribed ones are getting traction
for their use in specific cases.
By, drug type, the report on the orphan drugs market
encompasses biologics and non-biologics.
Regional Analysis:
Hike in investment capacity, better reimbursement policies,
various research institutes, presence of the leading pharmaceutical companies
and their strategic methods, and other reasons are providing the American
market for orphan drugs the much-needed boost owing to which the regional
market is way ahead of its peers. Both government and private players are
funding the regional research methods to ensure better growth prospects.
In Europe, the market is showing similar opportunities,
which can help various countries explore more and spur the growth. France,
Germany, Sweden, the UK, and others are taking the benefits of extensive
pharmaceutical infrastructure to support the regional market. The orphan drugs
market is also getting much demand from the Asia Pacific region. This is due to
the hike in disposable income, structural development in the healthcare sector,
better pharmaceutical interests shown to develop the regional market growth,
and others.
Competitive Analysis:
The global orphan
drugs market players is getting backed by like Mylan, Celgene Corporation,
F. Hoffmann-La Roche AG, Biogen, Takeda Pharmaceutical Company Limited, Novartis
AG, Eli Lilly and Company, Merck KGaA, Janssen Global Services LLC, Shire
Pharmaceutical, Sanofi, Vertex Pharmaceuticals Inc., Pfizer Inc., Alexion
Pharmaceuticals Inc., Bristol Meyer Squibb, and others. These companies are
trying to increase their operational scopes by launching several effective
measures as strategies to ensure their steps in the market get cushioned. These
methods are also to help the global market have a better growth opportunity in
the foreseeable future. The strategic moves include better pipeline products to
increase the FDA approval rate, mergers, acquisitions, and
collaborations.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Opioids are medications prescribed by
doctors and physicians to treat various levels of pain. These can include acute
pain and chronic non-cancer pain. They are also known as painkillers and used
to block pain signals from the brain. Market Research Future (MRFR) has
stressed the advantages of the intake of opioids as well as the efforts by
manufacturers to address various issues concerning the drugs.
Growth Drivers
The opioids
market is expected to reach USD 6,060.17 million at CAGR of 4.90% during
the forecast period 2022-2030. Pain management of various chronic diseases
remain the primary driver of the market. According to the National Institute of
Drug Abuse, nearly 200 million prescriptions were dispensed by U.S. pharmacies
in 2017. The large number of prescriptions is an indicator for the large scope
of the market.
Favorable reimbursement schemes for
covering the costs of opioids in palliative care can work in favor of the
market. Large number of patients diagnosed with various cancers can drive the
market demand for opioids till 2023. Rise in surgical procedures and road
accidents are other factors which can contribute to market demand due to the
need for pain relievers. All of these factors are predicted to push the market
to exhibit a CAGR of 7.12% during the forecast period.
Establishment of new guidelines to curb the
intake of opioids and reduce the addiction rates are expected to disrupt the
market in a positive manner. For instance, the sale of over-the-counter drugs
containing opioids is restricted, while stringent measures are undertaken regarding
prescriptions given by doctors. New policies by government-supported insurance
companies such as Medicare are limiting the dispensation rate of opioids to 7
days.
But misuse of viatris opioids and adverse
effects of the drugs which lead to addiction threaten the market growth.
Segments In-Detail:
MRFR has segmented the global opioids
market by product, application, and end-user.
Based on the product, the market is
segmented into immediate release/short-acting opioid and extended
release/long-acting opioid. Extended release comprises hydromorphone,
oxycodone, morphine, oxymorphone, and others. The extended release segment had
accounted for USD 12,750.91 million in 2017. This segment can expand in the
coming years due to rising prevalence of chronic diseases.
By application, it is segmented into
diarrhea suppression, deaddiction, cough suppression, pain relief, anesthesia,
and others. The pain relief segment is expected to be the dominant application
of the opioids market due to rise in pain management therapies. Moreover, new
guidelines for selling prescription drugs coupled with rise in palliative and
end-of-life care can boost segment growth. This in turn can drive the market
demand exponentially.
By end-user, the market caters to academic
research institutes, hospitals & clinics, and pharmacies.
Regional Analysis:
MRFR’s report takes a deep look into major
regions which include the Americas, Europe, Asia Pacific (APAC), and the Middle
East and Africa (MEA).
The Americas is predicted to be dominant in
the global market due to holding the largest market share due to awareness
among patients and the high intake of the drugs for pain alleviation. On the
other hand, Europe is expected to showcase prolific growth due to rise in
palliative care centers and strict regulations regarding opioid usage.
A Look at the Competition:
Prominent companies operating in the opioids
market players include Janssen Global Services, LLC, Egalet Corporation,
Teva Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi SA, Purdue Pharma L.P,
Boehringer Ingelheim GmbH, Allergan Inc., Sun Pharmaceutical Industries Ltd.,
Mallinckrodt, Vertice Pharma LLC, and West-Ward Pharmaceuticals
Corporation.
New in Research
Opioid-induced constipation is on the rise
due to being one of the side-effects during intake of pain relievers. In 2019,
Novartis has agreed to partner with Shinogi & Co Ltd, for bringing to
market Rizmoic in selected areas of the Netherlands, the U.K., and Germany.
According to a study published by the
researchers at the University of Pennsylvania School of Medicine, patients in
the United States and Canada are more likely to procure opioids due to the
large number of chronic diseases. High prevalence of minimally invasive
surgeries and prescription of codeine in post-operative care can bode well for
the global opioids market in the coming years.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.